An international survey of classification and treatment choices for group D retinoblastoma

Date
2017
Author
YAROVOY, Andrey
Pe'er, Jacob
MUNIER, Francis
BERRY, Jesse
HARBOUR, J. William
LUCENA, Evandro
MURRAY, Timothy G.
BHAGIA, Pooja
PAYSSE, Evelyn
CHANTADA, Guillermo L.
Moll, Annette C.
USHAKOVA, Tatiana
Plager, David A.
ZIYOVUDDIN, Islamov
LEAL, Carlos A.
MATERIN, Miguel A.
JI, Xun-Da
CURSINO, Jose W.
POLANIA, Rodrigo
Kiratli, Hayyam
ALL-ERICSSON, Charlotta
HONAVAR, Santosh G.
VISHNEVSKIA-DAI, Vicktoria
EPELMAN, Sidnel
Daniels, Anthony B.
Ling, Jeanie D.
TRAORE, Fousseyni
RAMIREZ-ORTIZ, Marco A.
Kebudi, Rejin
Tuncer, Samuray
SCELFO, Christina
FRANCIS, Jasmine H.
KHETAN, Vikas
JENKINS, Thomas
MARR, Brian
ABRAMSON, David H.
SHIELDS, Carol L.
Metadata
Show full item record
Abstract
AIM: To determine which IIRC scheme was used by retinoblastoma centers worldwide and the percentage of D eyes treated primarily with enucleation versus globe salvaging therapies as well as to correlate trends in treatment choice to IIRC version used and geographic region.
URI
http://hdl.handle.net/20.500.12627/61822
https://doi.org/10.18240/ijo.2017.06.20
Collections